Retractable Technologies (RVP) Capital Expenditures Growth (1y) (2011 - 2026)
Retractable Technologies (RVP) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.19 Bn | 120.97 Bn | 1.96 Bn | 17.46% |
| 2 | Becton Dickinson | 44.76 Bn | 43.95 Bn | 2.15 Bn | 9.65% |
| 3 | Alcon | 32.93 Bn | 31.28 Bn | 1.53 Bn | - |
| 4 | Medline | 32.80 Bn | 30.56 Bn | 1.84 Bn | -2.04% |
| 5 | Resmed | 29.51 Bn | 27.85 Bn | 890.98 Mn | 61.83% |
| 6 | West Pharmaceutical Services | 23.59 Bn | 23.15 Bn | 329.20 Mn | -42.55% |
| 7 | Solventum | 14.01 Bn | 13.45 Bn | 1.10 Bn | -22.94% |
| 8 | Cooper Companies | 13.77 Bn | 13.63 Bn | 735.40 Mn | 10.63% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 21.73% |
| 10 | Retractable Technologies | 20.49 Mn | -15.13 Mn | -838,408.00 | -92.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -92.85% |
| Dec 31, 2025 | -91.08% |
| Sep 30, 2025 | -88.69% |
| Jun 30, 2025 | 173.00% |
| Mar 31, 2025 | -61.56% |
| Dec 31, 2024 | 93.93% |
| Sep 30, 2024 | 455.49% |
| Jun 30, 2024 | 36.97% |
| Mar 31, 2024 | -51.58% |
| Dec 31, 2023 | -94.79% |
| Sep 30, 2023 | -95.72% |
| Jun 30, 2023 | -98.41% |
| Mar 31, 2023 | -90.59% |
| Dec 31, 2022 | -75.12% |
| Sep 30, 2022 | -60.05% |
| Jun 30, 2022 | -78.19% |
| Mar 31, 2022 | -60.60% |
| Dec 31, 2021 | 2.45% |
| Sep 30, 2021 | -8.17% |
| Jun 30, 2021 | 13,478.14% |